Accelerate diagnostics, inc. (AXDX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Jul'11
Cash flows from operating activities:
Net loss

-84,305

-88,326

-64,028

-66,374

-45,498

-30,933

-15,282

-378

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

2,602

2,561

2,196

2,351

1,782

817

286

2

Amortization of intangible assets

-

-

-

-

10

71

77

253

Amortization of investment discount

427

621

-326

-374

-188

-269

-76

0

Equity-based compensation

12,618

14,422

13,933

8,775

8,388

9,624

3,828

90

Amortization of debt discount and issuance costs

9,969

6,849

0

0

-

-

-

-

Impairment loss

-

-

-

-

-

3

11

0

Realized gain on sale of investments

-

-

-

6

0

0

-

-

Loss on disposal of property and equipment

-837

-678

-240

-23

0

0

-

-

Unrealized gain on investments

-

-

-

-

-

-

-

-14

Realized gain on sale of investments, interest and dividends reinvested

-

-

-

-

-

-

-

-6

(Increase) decrease in assets:
Accounts receivable

1,362

-86

1,912

-43

-1

54

-739

411

Inventory

3,655

4,223

7,759

0

0

-

-

2

Prepaid expense and other

752

250

459

-1,121

1,241

166

114

-1

Other current assets

-

-

-

-

12

0

0

-

Increase (decrease) in liabilities:
Accounts payable

988

-748

1,064

-1,242

329

1,336

205

2

Accrued liabilities, and other

-1,327

1,426

596

1,619

827

80

-356

1

Accrued interest

0

1,262

0

0

-

-

-

-

Deferred revenue and income

54

-904

36

-92

100

168

781

-10

Deferred compensation

-34

32

21

0

0

-

-

95

Net cash used in operating activities

-64,794

-67,756

-55,746

-53,408

-35,126

-18,785

-9,749

448

Cash flows from investing activities:
Purchases of equipment

330

998

2,966

2,409

3,656

1,933

1,158

75

Contribution to deferred compensation trust

-

-

-

-

-

-

-

-75

Purchase of marketable securities

50,226

120,556

82,333

74,075

12,418

7,657

12,014

0

Proceeds from sales of marketable securities

14,500

3,000

11,522

9,716

141

861

0

-

Maturities of marketable securities

88,867

98,416

48,049

17,200

13,258

5,357

0

-

Net cash (used in) provided by investing activities

52,811

-20,138

-25,728

-49,568

-2,675

-3,372

-13,172

-150

Cash flows from financing activities:
Common stock issuance cost

-

-

-

814

0

0

-

-

Proceeds from exercise of options and warrants

5,365

3,749

6,606

226

104,165

44,875

19,912

0

Recovery of related party short-swing profits

-

-

-

866

0

0

-

-

Payments on capital lease obligations

-

-

-

13

147

107

0

-

Proceeds from exercise of options

1,458

583

83,821

1,497

805

923

20,969

194

Proceeds from issuance of convertible note

0

171,500

0

0

-

-

-

-

Prepayment of forward stock repurchase transaction

0

45,069

0

0

-

-

-

-

Payment of debt issuance costs

0

4,992

0

0

-

-

-

-

Net cash provided by financing activities

6,823

125,771

90,427

1,762

104,823

45,691

40,881

194

Effect of exchange rate on cash

-86

-130

316

-127

0

0

-

-

(Decrease) increase in cash and cash equivalents

-5,246

37,747

9,269

-101,341

67,022

23,534

17,960

492

Non-cash investing activities:
Non-cash investing activities:
Transfer of instruments from inventory to property and equipment

3,361

4,767

0

0

-

-

-

-

Supplemental cash flow information:
Interest paid

4,288

2,001

0

0

-

-

-

-

Income taxes paid, net of refunds

41

651

0

0

-

-

-

-